Meibomian Gland Dysfunction Global Market Report 2025
상품코드:1769655
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
마이봄선 기능 장애 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 성장은 팬데믹 이후 디지털 생활 방식의 확산, 콘택트 렌즈 관련 합병증의 증가, 최소 침습적 안과 치료에 대한 선호도 상승, 열 펄스 치료법의 광범위한 적용, 개인 맞춤형 안과 관리에 대한 관심 강화 등에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 마이보그래피 영상 기술의 발전, 비침습적 모니터링 도구의 개발, 안과 및 피부과 치료의 통합, 선 평가에 머신 러닝의 사용, 지질 기반 안약 제형의 혁신 등이 있습니다.
안과 질환의 발병률이 증가함에 따라 향후 몇 년 동안 마이봄샘 기능 장애(MGD) 시장이 확대될 것으로 예상됩니다. 안과 질환은 눈이나 시각 시스템에 영향을 미치고 그 구조, 기능 또는 전반적인 건강을 손상시키는 모든 상태 또는 장애를 포함합니다. 안과 질환의 급증은 주로 화면 시청 시간의 증가와 디지털 눈의 피로로 인해 발생하며, 이는 건조함, 시야 흐림, 장기간 블루라이트 노출로 인한 잠재적인 장기적인 망막 손상 등의 증상을 유발합니다. 마이봄선 기능 장애는 눈물막을 불안정하게 만들어 염증, 건조증, 안구 표면 장애 위험을 높여 눈 질환을 악화시킵니다. 예를 들어, 2023년 9월 영국 기반 대표 회원 단체인 안과 의사 협회(Association of Optometrists)의 보고서에 따르면 2022년 잉글랜드에서 시력 장애 신규 진단 사례가 22,552건 기록되었습니다. 이 중 1,344건은 당뇨병성 안과 질환, 3,614건은 녹내장과 관련되었으며, 1만 865건은 연령 관련 황반 변성으로 인해 발생했습니다. 따라서 안과 질환 사례의 증가가 마이봄선 기능 장애(MGD) 시장 성장을 촉진하고 있습니다.
마이봄선 기능 장애 시장의 선도 기업들은 눈물 증발을 최소화하고 안구 건조증 증상을 완화하기 위한 처방용 안약과 같은 혁신적인 치료법 개발에 집중하고 있습니다. 항염증제 또는 항생제 제제를 포함한 이러한 처방용 안약은 염증을 완화하고 선 막힘을 제거하며 눈물막의 안정성을 높임으로써 마이봄선 기능 장애를 관리하는 데 도움이 됩니다. 예를 들어, 2023년 5월, 캐나다의 안과 치료제 제조업체인 Bausch + Lomb Corporation은 안구 건조증(DED) 치료를 위해 설계된 첨단 처방 안약인 MIEBO(퍼플루오로헥실옥탄 안과용 용액)를 출시했습니다. MIEBO는 DED의 주요 원인인 눈물 증발을 표적으로 특별히 제조된 최초이자 유일한 처방 안약입니다. 이 약은 눈 표면에 오래 지속되는 보호막을 형성합니다. 이 혁신적인 무수 제제는 특히 마이봄샘 기능 장애와 관련된 안구 건조증 증상을 겪는 사람들에게 효과적이고 지속적인 완화를 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 마이봄선 기능 장애 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 마이봄선 기능 장애 시장 : 성장률 분석
세계의 마이봄선 기능 장애 시장 실적 : 규모와 성장(2019-2024년)
세계의 마이봄선 기능 장애 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 마이봄선 기능 장애 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 마이봄선 기능 장애 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
의약품
수술
라이프 스타일 변화
세계의 마이봄선 기능 장애 시장 : 기능 장애 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
폐색성 마이봄선 기능 장애
증발성 마이봄선 기능 장애
혼합성 마이봄선 기능 장애
세계의 마이봄선 기능 장애 시장 : 병 중증도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경미한 마이봄선 기능 장애
중간 정도의 마이봄선 기능 장애
심한 마이봄선 기능 장애
세계의 마이봄선 기능 장애 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 클리닉
약국
온라인 소매업체
세계의 마이봄선 기능 장애 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
안과 클리닉
재택 케어
세계의 마이봄선 기능 장애 시장 : 의약품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
국소 항생제
국소 스테로이드
윤활점 안약
국소용 사이클로스포린
오메가-3 보충
세계의 마이봄선 기능 장애 시장 : 수술 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
마이봄선 프로빙
강력한 펄스광(IPL) 요법
온열맥동치료
브레프엑스
세계의 마이봄선 기능 장애 시장 : 라이프 스타일 변화 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
온습포요법
눈꺼풀의 위생
식생활 조정
눈꺼풀 연습
제7장 지역별, 국가별 분석
세계의 마이봄선 기능 장애 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 마이봄선 기능 장애 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
마이봄선 기능 장애 시장 : 경쟁 구도
마이봄선 기능 장애 시장 : 기업 프로파일
Johnson And Johnson
Alcon Inc.
Cleveland Clinic Foundation
Bausch Lomb Corporation
Santen Pharmaceutical
제31장 기타 주요 기업 및 혁신 기업
Lumenis Ltd
Topcon Healthcare Solutions Inc.
AFT Pharmaceuticals
Sight Sciences Inc.
OASIS Medical Inc.
OCuSOFT Inc.
Novaliq GmbH
Scope Ophthalmics Ltd
Medmont International Pty Ltd
Azura Ophthalmics Ltd
BlephEx LLC
Bruder Healthcare Company
ESW Vision Inc.
MiBo Medical Group Inc.
Kala Pharmaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
마이봄선 기능 장애 시장(2029년) : 새로운 기회를 제공하는 국가
마이봄선 기능 장애 시장(2029년) : 새로운 기회를 제공하는 부문
마이봄선 기능 장애 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Meibomian gland dysfunction (MGD) is a prevalent eye condition characterized by blocked or improperly functioning meibomian glands in the eyelids, which results in poor-quality oil production. This disruption in the tear film leads to symptoms such as dryness, irritation, inflammation, and blurred vision. MGD is a primary contributor to dry eye disease and can vary in severity from mild to severe.
The primary treatment options for MGD include medication, surgery, and lifestyle modifications. Medication involves the use of drugs or therapeutic substances under medical supervision to treat, manage, or prevent the condition. MGD can be classified into obstructive, evaporative, or mixed types based on the nature of the dysfunction. The severity is typically categorized as mild, moderate, or severe. Treatments are distributed through various channels, including hospitals, clinics, pharmacies, and online platforms, and are designed to serve end users such as hospitals, ophthalmology clinics, and home care environments.
The meibomian gland dysfunction market research report is one of a series of new reports from The Business Research Company that cover meibomian gland dysfunction market statistics, including the meibomian gland dysfunction industry's global market size, regional shares, competitors with the meibomian gland dysfunction market share, detailed meibomian gland dysfunction market segments, market trends and opportunities, and any further data you may need to thrive in the meibomian gland dysfunction market. This meibomian gland dysfunction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The meibomian gland dysfunction market size has grown strongly in recent years. It will grow from $4.13 billion in 2024 to $4.42 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to greater awareness of dry eye disorders, a rising aging population, increased screen time across all age groups, a growing prevalence of lifestyle-related eye conditions, and a higher incidence of allergic reactions and environmental irritants.
The meibomian gland dysfunction market size is expected to see strong growth in the next few years. It will grow to $5.74 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to the rising adoption of digital lifestyles following the pandemic, an increasing incidence of contact lens-related complications, a growing preference for minimally invasive eye treatments, wider use of thermal pulsation therapies, and an enhanced focus on personalized eye care. Key trends expected during this period include advancements in meibography imaging technology, the development of non-invasive monitoring tools, the integration of ophthalmic and dermatological care, the use of machine learning for gland assessment, and innovations in lipid-based eye drop formulations.
The increasing incidence of eye diseases is anticipated to drive the expansion of the meibomian gland dysfunction (MGD) market in the coming years. Eye disease encompasses any condition or disorder affecting the eye or visual system, compromising its structure, function, or overall health. The surge in eye disease cases is largely due to heightened screen time and digital eye strain, which lead to symptoms like dryness, blurred vision, and potential long-term retinal damage from extended blue light exposure. Meibomian gland dysfunction exacerbates eye diseases by destabilizing the tear film, causing inflammation, dryness, and elevating the risk of ocular surface disorders. For example, in September 2023, a report from the Association of Optometrists, a UK-based representative membership body, revealed that in 2022, England recorded 22,552 new certifications for vision impairment. Among these, 1,344 cases were due to diabetic eye disease, 3,614 were linked to glaucoma, and 10,865 were caused by age-related macular degeneration. Thus, the growing number of eye disease cases is fueling the growth of the meibomian gland dysfunction (MGD) market.
Leading companies in the meibomian gland dysfunction market are concentrating on the development of innovative treatments, such as prescription eye drop solutions, aimed at minimizing tear evaporation and alleviating dry eye symptoms. These prescription drops, including anti-inflammatory or antibiotic formulations, aid in managing meibomian gland dysfunction by reducing inflammation, clearing gland obstructions, and enhancing tear film stability. For example, in May 2023, Bausch + Lomb Corporation, a Canada-based eye care company, launched MIEBO (perfluorohexyloctane ophthalmic solution), an advanced prescription eye drop designed to treat dry eye disease (DED). MIEBO is the first and only prescription drop specifically formulated to target tear evaporation, the primary cause of DED. It creates a long-lasting, protective layer on the eye's surface. This innovative, water-free formula offers effective and sustained relief, especially for individuals experiencing dry eye symptoms linked to meibomian gland dysfunction.
In July 2023, CS Pharmaceuticals Limited, a pharmaceutical company based in the UK, acquired AxeroVision Inc. for an undisclosed sum. Through this acquisition, CS Pharmaceuticals intends to enhance its ophthalmology portfolio and advance the development of novel therapies for dry eye disease associated with meibomian gland dysfunction (MGD), targeting a significant unmet medical need. AxeroVision Inc. is a biotechnology company based in the US that specializes in creating innovative treatments for meibomian gland dysfunction.
Major players in the meibomian gland dysfunction market are Johnson And Johnson, Alcon Inc., Cleveland Clinic Foundation, Bausch + Lomb Corporation, Santen Pharmaceutical, Lumenis Ltd, Topcon Healthcare Solutions Inc., AFT Pharmaceuticals, Sight Sciences Inc., OASIS Medical Inc., OCuSOFT Inc., Novaliq GmbH, Scope Ophthalmics Ltd, Medmont International Pty Ltd, Azura Ophthalmics Ltd, BlephEx LLC, Bruder Healthcare Company, ESW Vision Inc., MiBo Medical Group Inc., and Kala Pharmaceuticals Inc.
North America was the largest region in the meibomian gland dysfunction market in 2024. The regions covered in meibomian gland dysfunction report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the meibomian gland dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The meibomian gland dysfunction market consists of revenues earned by entities by providing services such as diagnostic services, customized dry eye management plans, and thermal pulsation treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The meibomian gland dysfunction market also includes sales of artificial tears and lubricating eye drops, omega-3 supplements, prescription medications, and intense pulsed light (IPL) therapy devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Meibomian Gland Dysfunction Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on meibomian gland dysfunction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for meibomian gland dysfunction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The meibomian gland dysfunction market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment Type: Medication; Surgery; Lifestyle Modifications
3. Meibomian Gland Dysfunction Market Trends And Strategies
4. Meibomian Gland Dysfunction Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Meibomian Gland Dysfunction Growth Analysis And Strategic Analysis Framework
5.1. Global Meibomian Gland Dysfunction PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Meibomian Gland Dysfunction Market Growth Rate Analysis
5.4. Global Meibomian Gland Dysfunction Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Meibomian Gland Dysfunction Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Meibomian Gland Dysfunction Total Addressable Market (TAM)
6.1. Global Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Surgery
Lifestyle Modifications
6.2. Global Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Obstructive Meibomian Gland Dysfunction
Evaporative Meibomian Gland Dysfunction
Mixed Meibomian Gland Dysfunction
6.3. Global Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild Meibomian Gland Dysfunction
Moderate Meibomian Gland Dysfunction
Severe Meibomian Gland Dysfunction
6.4. Global Meibomian Gland Dysfunction Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Pharmacies
Online Retailers
6.5. Global Meibomian Gland Dysfunction Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ophthalmology Clinics
Home Care Settings
6.6. Global Meibomian Gland Dysfunction Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Antibiotics
Topical Steroids
Lubricating Eye Drops
Topical Cyclosporine
Omega-3 Supplements
6.7. Global Meibomian Gland Dysfunction Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Meibomian Gland Probing
Intense Pulsed Light (IPL) Therapy
Thermal Pulsation Treatment
BlephEx
6.8. Global Meibomian Gland Dysfunction Market, Sub-Segmentation Of Lifestyle Modifications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Warm Compress Therapy
Lid Hygiene
Dietary Adjustments
Blinking Exercises
7. Meibomian Gland Dysfunction Market Regional And Country Analysis
7.1. Global Meibomian Gland Dysfunction Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Meibomian Gland Dysfunction Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Meibomian Gland Dysfunction Market
9.1. China Meibomian Gland Dysfunction Market Overview
9.2. China Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Meibomian Gland Dysfunction Market
10.1. India Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Meibomian Gland Dysfunction Market
11.1. Japan Meibomian Gland Dysfunction Market Overview
11.2. Japan Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Meibomian Gland Dysfunction Market
12.1. Australia Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Meibomian Gland Dysfunction Market
13.1. Indonesia Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Meibomian Gland Dysfunction Market
14.1. South Korea Meibomian Gland Dysfunction Market Overview
14.2. South Korea Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Meibomian Gland Dysfunction Market
15.1. Western Europe Meibomian Gland Dysfunction Market Overview
15.2. Western Europe Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Meibomian Gland Dysfunction Market
16.1. UK Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Meibomian Gland Dysfunction Market
17.1. Germany Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Meibomian Gland Dysfunction Market
18.1. France Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Meibomian Gland Dysfunction Market
19.1. Italy Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Meibomian Gland Dysfunction Market
20.1. Spain Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Meibomian Gland Dysfunction Market
21.1. Eastern Europe Meibomian Gland Dysfunction Market Overview
21.2. Eastern Europe Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Meibomian Gland Dysfunction Market
22.1. Russia Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Meibomian Gland Dysfunction Market
23.1. North America Meibomian Gland Dysfunction Market Overview
23.2. North America Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Meibomian Gland Dysfunction Market
24.1. USA Meibomian Gland Dysfunction Market Overview
24.2. USA Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Meibomian Gland Dysfunction Market
26.1. South America Meibomian Gland Dysfunction Market Overview
26.2. South America Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Meibomian Gland Dysfunction Market
27.1. Brazil Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Meibomian Gland Dysfunction Market
28.1. Middle East Meibomian Gland Dysfunction Market Overview
28.2. Middle East Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Meibomian Gland Dysfunction Market
29.1. Africa Meibomian Gland Dysfunction Market Overview
29.2. Africa Meibomian Gland Dysfunction Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Meibomian Gland Dysfunction Market, Segmentation By Dysfunction Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Meibomian Gland Dysfunction Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Meibomian Gland Dysfunction Market Competitive Landscape And Company Profiles
